In the combined cohort, BD-tau concentrations were higher in patients with unfavorable outcomes across all stroke subtypes (Figure 2A), and for large artery atherosclerosis, cardioembolic, and cryptogenic stroke, the association was significant in multivariable analyses (Figure 2B; eTable 4, links.lww.com/WNL/D357). The gene discussed is MAPT; the disease is Stroke.